Armistice Capital’s Achillion Pharmaceuticals ACHN Stock Holding History

Armistice Capital’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,500,000	Closed	-$7.4M	–	92
2019 Q1	$7.4M	Sell	2,500,000 -1,800,000	-42%	-$4.42M	0.61%	46
2018 Q4	$6.84M	Buy	4,300,000 +2,300,000	+115%	+$6.5M	0.75%	39
2018 Q3	$7.36M	Sell	2,000,000 -2,000,000	-50%	-$5.96M	0.6%	52
2018 Q2	$11.3M	Sell	4,000,000 -296,000	-7%	-$1.01M	0.98%	43
2018 Q1	$15.9M	Buy	+4,296,000	New	+$14.1M	1.47%	33
2017 Q4	–	Sell	-1,020,000	Closed	-$4.58M	–	93
2017 Q3	$4.58M	Buy	+1,020,000	New	+$4.53M	0.81%	50

Other funds holding ACHN

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MAK Capital One New York $604M AUM 29.02% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return